These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35249326)

  • 1. Efficacy and safety of intraventricular polymyxin B plus continuous ventricular drainage for the treatment of intracranial infection caused by drug-resistant Acinetobacter baumannii.
    Chen L; Li X; Li D; Dong X; Chen H
    Ann Palliat Med; 2022 Feb; 11(2):490-497. PubMed ID: 35249326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR
    Pan S; Huang X; Wang Y; Li L; Zhao C; Yao Z; Cui W; Zhang G
    Antimicrob Resist Infect Control; 2018; 7():8. PubMed ID: 29387342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Clinical Study on the Use of Intraventricular Polymyxin B Supplemented by Continuous External Ventricular Drainage in the Treatment of Drug-Resistant Gram-Negative Bacilli Intracranial Infection.
    Chen H; Guo X; Xie D; Dong X; Niu J; Chen G
    Infect Drug Resist; 2020; 13():2963-2970. PubMed ID: 32904679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential intraventricular injection of tigecycline and polymyxin B in the treatment of intracranial Acinetobacter baumannii infection after trauma: a case report and review of the literature.
    Zhong L; Shi XZ; Su L; Liu ZF
    Mil Med Res; 2020 May; 7(1):23. PubMed ID: 32389124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Presentations and Outcomes of Post-Operative Central Nervous System Infection Caused by Multi-Drug-Resistant/Extensively Drug-Resistant
    Liang W; Yuan-Run Z; Min Y
    Surg Infect (Larchmt); 2019 Sep; 20(6):460-464. PubMed ID: 30942663
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraventricular polymyxin B for the treatment of neonatal meningo-ventriculitis caused by multi-resistant Acinetobacter baumannii--case report and review of literature.
    Piparsania S; Rajput N; Bhatambare G
    Turk J Pediatr; 2012; 54(5):548-54. PubMed ID: 23427525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit.
    Holloway KP; Rouphael NG; Wells JB; King MD; Blumberg HM
    Ann Pharmacother; 2006 Nov; 40(11):1939-45. PubMed ID: 17018688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long course of polymyxin B for the treatment of brain abscess caused by carbapenem resistant Acinetobacter baumannii: a case report].
    Sun X; Zhang Y; Zhang L; Yao L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Nov; 33(11):1370-1372. PubMed ID: 34980311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acinetobacter baumannii meningitis in children: a case series and literature review.
    Xiao J; Zhang C; Ye S
    Infection; 2019 Aug; 47(4):643-649. PubMed ID: 30328074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymyxin B in Combination with Antimicrobials Lacking In Vitro Activity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections.
    Rigatto MH; Vieira FJ; Antochevis LC; Behle TF; Lopes NT; Zavascki AP
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6575-80. PubMed ID: 26259799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of extensively drug-resistant
    Guo W; Guo SC; Li M; Li LH; Qu Y
    Antimicrob Resist Infect Control; 2018; 7():22. PubMed ID: 29456841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis.
    De Bonis P; Lofrese G; Scoppettuolo G; Spanu T; Cultrera R; Labonia M; Cavallo MA; Mangiola A; Anile C; Pompucci A
    Eur J Neurol; 2016 Jan; 23(1):68-75. PubMed ID: 26228051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal Injection of Tigecycline and Polymyxin B in the Treatment of Extensively Drug-Resistant Intracranial
    Li Z; An Y; Li L; Yi H
    Infect Drug Resist; 2022; 15():1411-1423. PubMed ID: 35392365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of Using Intraventricular Plus Intravenous Polymyxin B in Post-neurosurgical Patients With Multi/Extensively Drug-Resistant Gram-Negative Bacteria-Induced Intracranial Infection.
    Li H; Yu W; Wang G; Cai H
    Front Med (Lausanne); 2022; 9():913364. PubMed ID: 35872774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
    J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on the arsenal for multidrug-resistant Acinetobacter infections: polymyxin antibiotics.
    Kassamali Z; Jain R; Danziger LH
    Int J Infect Dis; 2015 Jan; 30():125-32. PubMed ID: 25461655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.
    Thomas VM; Brown RM; Ashcraft DS; Pankey GA
    Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical manifestations and risk factors of poor prognosis of
    Gao JG; Ye Y
    Zhonghua Yi Xue Za Zhi; 2018 Oct; 98(37):2973-2977. PubMed ID: 30392250
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of Carbapenem-Resistant Multidrug-Resistant Gram-Negative Bacilli with Intracerebroventricular Injection of Polymyxin B: A Retrospective Study.
    Liu D; Niu J; Chen G; Xu L
    Infect Drug Resist; 2022; 15():7653-7666. PubMed ID: 36579127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthelmintic closantel enhances bacterial killing of polymyxin B against multidrug-resistant Acinetobacter baumannii.
    Tran TB; Cheah SE; Yu HH; Bergen PJ; Nation RL; Creek DJ; Purcell A; Forrest A; Doi Y; Song J; Velkov T; Li J
    J Antibiot (Tokyo); 2016 Jun; 69(6):415-21. PubMed ID: 26669752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.